Moridani Majid Y, Tilbrook Gary S, Khodr Hicham H, Hider Robert C
Department of Pharmacy, King's College London, UK.
J Pharm Pharmacol. 2002 Mar;54(3):349-64. doi: 10.1211/0022357021778592.
Novel 3-hydroxypyridin-4-one containing tridentate ligands were synthesised and their physicochemical properties characterised, including ionisation constants and stoichiometric titration with Fe(III). There is an urgent demand for orally active iron chelators with potential for the treatment of thalassaemia. In principle, tridentate ligands are likely to be more kinetically stable than bidentate molecules, but to date no satisfactory molecules have been identified. Fe(III) stability constants were assessed by competition with the hexadentate ligand EDTA. In all cases no evidence was found for a tridentate mode of iron chelation; instead the ligands behaved as bidentate hydroxypyridinones. As a consequence they provide no advantage over the more simple alkyl hydroxypyridinones.
合成了含新型3-羟基吡啶-4-酮的三齿配体,并对其物理化学性质进行了表征,包括电离常数以及与Fe(III)的化学计量滴定。迫切需要具有治疗地中海贫血潜力的口服活性铁螯合剂。原则上,三齿配体在动力学上可能比双齿分子更稳定,但迄今为止尚未鉴定出令人满意的分子。通过与六齿配体EDTA竞争来评估Fe(III)的稳定性常数。在所有情况下,均未发现铁螯合的三齿模式的证据;相反,这些配体表现为双齿羟基吡啶酮。因此,它们相对于更简单的烷基羟基吡啶酮没有优势。